"Weight-ing" for an answer on optimal valganciclovir prophylaxis dosing in pediatric solid organ transplantation recipients
- PMID: 36945839
- DOI: 10.1111/petr.14494
"Weight-ing" for an answer on optimal valganciclovir prophylaxis dosing in pediatric solid organ transplantation recipients
References
REFERENCES
-
- Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation infectious diseases Community of Practice. Clin Transplant. 2019;33:e13512.
-
- Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19:759-773.
-
- Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the Management of Cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900-931.
-
- Valcyte Prescribing Information. Genentech 2021.
-
- Hayes M, Boge CLK, Sharova A, et al. Antiviral toxicities in pediatric solid organ transplant recipients. Am J Transplant. 2022;22:3012-3020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
